Treatment with the calcium chelator BAPTA to reduce the intracellular Ca2+ level downregulated STUB1 in CRTAC1-overexpressing NSCLC cells treated with cisplatin at the protein (Fig. 7E, F) and mRNA levels (Fig. 7G, H). The gene discussed is CRTAC1; the disease is non-small cell lung carcinoma.